One clinical trial is assessing whether semaglutide, used in weight loss drugs, could slow the progression of dementia ...

News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, ...

Dementia experts have said that "hope is on the horizon" after a new review shows a rise in the number of potential drugs ...

The National Institute for Health and Care Excellence is taking more evidence and is expected to announce its decision in the ...

The average weight for women in the U.S. is 170.8 pounds, and the average height is 5 feet, 3 inches tall. These are ...

HIMS posted stellar Q1 FY 2025; growth fueled by ~2.4M subscribers and $84 average monthly revenue per user. Click here to ...

Dementia experts have said that “hope is on the horizon” after a new review shows a rise in the number of potential drugs that could treat or prevent Alzheimer’s disease. Some 138 treatments are being ...

A third of the drugs that are currently being trialled are 'repurposed' medications that are already being used to tackle ...

American teens are increasingly turning to the weight-loss drug Wegovy, as more families and their doctors gain confidence in ...

Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...

Medicare no longer covers Wegovy specifically for weight loss purposes, though coverage may still be available when ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...